These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13679452)

  • 41. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of p27kip1 in urinary bladder urothelial carcinoma.
    Fu TY; Tu MS; Tseng HH; Wang JS
    Int J Urol; 2007 Dec; 14(12):1084-7. PubMed ID: 18036045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
    Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
    Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
    Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF
    Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G; Carboni N; Baldini L; Intini D; Colombi M; Bertolini F; Valentini S; Maisonneuve P; Viale G; Neri A
    Hum Pathol; 2003 Jan; 34(1):41-7. PubMed ID: 12605365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion.
    Müller-Höcker J; Babaryka G; Schmid I; Jung A
    Pathol Res Pract; 2008; 204(8):589-97. PubMed ID: 18358634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunomorphological characteristics and criteria for predicting gastrointestinal stromal tumors].
    Kravtsov VG; Zaĭrat'iants OV; Shirin Ch; Shakhmurov M; Shabat V; Kripshpon I; Alin A; Avinoach I; Avni J
    Arkh Patol; 2007; 69(5):25-8. PubMed ID: 18074815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of cyclin E and p27 expression in malignant ovarian germ cell tumors: correlation with the cell proliferation activity and clinicopathologic features.
    Kawauchi S; Yamamoto Y; Uchida K; Chochi Y; Kondo T; Oga A; Sasaki K
    Oncol Rep; 2006 Nov; 16(5):1029-33. PubMed ID: 17016588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression and clinical significance of p27 protein and cyclinD1 protein in gastrointestinal stromal tumors].
    Yang XD; Zuo M; Pan K
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1352-4. PubMed ID: 16029637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
    Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
    Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication protein A: a reliable biologic marker of prognostic and therapeutic value in human astrocytic tumors.
    Kanakis D; Levidou G; Gakiopoulou H; Eftichiadis C; Thymara I; Fragkou P; Trigka EA; Boviatsis E; Patsouris E; Korkolopoulou P
    Hum Pathol; 2011 Oct; 42(10):1545-53. PubMed ID: 21496876
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study.
    Sökmensüer C; Gedikoglu G; Uzunalimoglu B
    Hepatogastroenterology; 2001; 48(39):720-3. PubMed ID: 11462912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.
    Zhu J; Abbruzzese JL; Izzo J; Hittelman WN; Li D
    Cancer Genet Cytogenet; 2005 May; 159(1):10-7. PubMed ID: 15860351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.